Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 13-Sep 2017. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 99058401000001119 | Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 99058501000001115 | Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) | Is a | Necitumumab 800mg/50ml solution for infusion vials | false | Inferred relationship | Existential restriction modifier | ||
| Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) | Has specific active ingredient | Necitumumab | false | Inferred relationship | Existential restriction modifier | ||
| Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) | Has dispensed dose form | Conventional release solution for infusion | false | Inferred relationship | Existential restriction modifier | ||
| Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) | Has excipient | Polysorbate | false | Inferred relationship | Existential restriction modifier | ||
| Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) | Is a | Actual medicinal product | false | Inferred relationship | Existential restriction modifier | ||
| Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) | Is a | Portrazza | false | Inferred relationship | Existential restriction modifier | ||
| Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) | Has active ingredient | Monoclonal antibody | false | Inferred relationship | Existential restriction modifier | ||
| Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) | Has specific active ingredient | Necitumumab | false | Inferred relationship | Existential restriction modifier | ||
| Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) | Has manufactured dose form | Conventional release solution for infusion | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial | Has AMP | False | Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR